Cantargia AB has announced IL-17 as the second target for its bispecific antibody, CAN-14. CAN-14 is in preclinical ...
IL-12 is composed of IL-12p35 and IL-12p40 and is known to drive type 1 immune responses. At The Liver Meeting, Regeneron ...
Antibody-drug conjugates have garnered notice aplenty lately in endometrial cancer, but Faeth Therapeutics Inc. has chalked mid-stage progress with another approach: Piktor, which consists of an ...
Out with the guidance, in with the rules. For the first time since the 2022 Inflation Reduction Act mandated that Medicare ...
Argenx SE plans to acquire the remaining shares of Unnatural Products Inc. that it does not already own for up to $1.15 billion, including $550 million up front and up to $595 million tied to ...
A rare risk of vision loss and the potential for malignancies are on the U.S. FDA’s radar as it orders a new safety warning for GLP-1 drugs and investigates the risk of neoplasia with Novartis AG’s ...
Shares of Vir Biotechnology Inc. got a boost on positive data from the first of three phase III studies testing the combination regimen of elebsiran and tobevibart in chronic hepatitis D (CHD), ...
From voice analysis and coronary CT-based technologies to smartwatch ECGs, AI-powered tools are moving further into cardiovascular care to support diagnosis and monitoring.
Messenger RNA specialist SRTD Biotech GmbH has closed a €31.5 million (US$31 million) seed round to fund preclinical development of targeted therapies that express their payloads only within diseased ...
Glioblastoma may be more organized than previously thought. Despite occurring in different brain regions, or being classified into different tumor subtypes, this aggressive brain cancer has lacked a ...
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. has reported new CDK2/cyclin E1 and/or CDK4/cyclin D1 and/or CDK6/cyclin D3 inhibitors potentially useful for the treatment of cancer.
Sunshine Lake Pharma Co. Ltd. has disclosed new P2X purinoceptor 3 (P2RX3; P2X3) modulators potentially useful for the treatment of pain, respiratory and genitourinary disorders.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results